RSCF REFLECT SCIENTIFIC, INC.
Laboratory Apparatus & Furniture · OTC · SEC CIK 1103090 · Fiscal year ends 12/31
Financial factors as of 2024-09-30 (2024Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY25.6%
TTM net income YoY90.3%
TTM EPS YoY—
Revenue 3-yr CAGR-13.7%
Net income 3-yr CAGR—
Margins
Gross margin58.5%
Operating margin-3.6%
Net margin-1.7%
FCF margin—
EBITDA margin—
Returns
ROE-1.4%
ROA-1.2%
ROIC (approx.)-5.5%
Asset turnover0.68x
Leverage & solvency
Liabilities / assets11.1%
Debt / equity0.00x
Current ratio15.03x
Interest coverage—
Cash quality & payout
Operating cash flow / net income10.50x
Accruals ratio11.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2024Q32024-09-30 | 2024Q22024-06-30 | 2024Q12024-03-31 | 2023Q4*2023-12-31 | 2023Q32023-09-30 | 2023Q22023-06-30 | 2023Q12023-03-31 | 2022Q4*2022-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $514,023 | $590,071 | $428,755 | $188,769 | $525,874 | $124,384 | $241,127 | $478,873 |
| Cost of revenue | $186,197 | $231,514 | $186,966 | $110,362 | $195,888 | $63,850 | $113,633 | $269,833 |
| Gross profit | $327,826 | $358,557 | $241,789 | $78,407 | $329,986 | $60,534 | $127,494 | $209,040 |
| R&D expense | $3,092 | $4,605 | $7,375 | $9,014 | $9,082 | $5,380 | $6,066 | $14,951 |
| SG&A expense | $87,552 | $107,555 | $132,304 | $115,956 | $84,331 | $81,361 | $106,992 | $103,855 |
| Operating income | $99,239 | $98,343 | -$40,504 | -$219,559 | $80,896 | -$180,776 | -$147,839 | -$61,312 |
| Pretax income | $110,030 | $98,343 | -$31,971 | -$216,365 | $86,264 | -$180,776 | -$147,839 | -$61,312 |
| Income tax | $100 | — | — | $0 | $0 | $312 | — | $0 |
| Net income | $109,930 | $108,987 | -$31,971 | -$216,365 | $86,264 | -$181,088 | -$147,839 | -$61,312 |
| EPS (basic) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 85.66M | 85.66M | 85.66M | — | 85.66M | 85.21M | 85.21M | — |
| Banking | ||||||||
| Net interest income | — | $10,644 | — | — | — | -$312 | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $1.03M | $1.10M | $1.10M | $1.28M | $1.34M | $1.41M | $1.20M | $1.38M |
| Receivables | $272,098 | $110,592 | $335,003 | $108,191 | $120,182 | $92,717 | $108,368 | $129,329 |
| Inventory | $775,676 | $835,667 | $950,917 | $972,293 | $920,954 | $877,086 | $850,620 | $797,352 |
| Current assets | $2.09M | $2.06M | $2.40M | $2.37M | $2.39M | $2.40M | $2.16M | $2.33M |
| Goodwill | $60,000 | $60,000 | $60,000 | $60,000 | $60,000 | $60,000 | $60,000 | $60,000 |
| Total assets | $2.34M | $2.33M | $2.68M | $2.67M | $2.71M | $2.49M | $2.27M | $2.45M |
| Current liabilities | $139,252 | $216,075 | $655,176 | $596,366 | $434,408 | $509,168 | $111,255 | $149,592 |
| Total liabilities | $258,546 | $357,041 | $816,167 | $776,329 | $631,766 | $509,168 | $111,255 | $149,592 |
| Shareholders' equity | $2.08M | $1.97M | $1.86M | $1.89M | $2.07M | $1.98M | $2.16M | $2.30M |
| Shares outstanding | 85.66M | 85.66M | 85.66M | 85.66M | 85.21M | 85.21M | 85.21M | 85.21M |
| Cash flow statement | ||||||||
| Operating cash flow | -$72,288 | $3,272 | -$178,527 | -$61,495 | -$69,312 | $209,689 | -$182,858 | $57,221 |
| Stock-based compensation | — | — | — | $34,375 | $6,875 | $6,875 | $6,875 | $6,875 |
Free plan shows the latest 8 periods; Pro shows all 58 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.